News
AI Biotech Recursion Commits $88M to a Pair of Drug Discovery Acquisitions Recursion Pharmaceuticals is acquiring two Canada-based artificial intelligence startups, Cyclica and Valence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback